1e
19
1
49
2
2
18
1b
1d
18
33
55
1d
2 29
1d
25
H. Jorge Baluarte, MD
88
55
Emeritus Professor CE of Pediatrics (Nephrology)
7
61
Department: Pediatrics
4
1
b
1d
46
Contact information
55
4
3
3
3
2
4
b
1f
55
The Children's Hospital of Philadelphia
49 34th Street and Civic Center Blvd
Philadelphia, PA 19104-4399
26
49 34th Street and Civic Center Blvd
Philadelphia, PA 19104-4399
31
Office: 2155672422
30
8f
30
Email:
baluarte@email.chop.edu
12
baluarte@email.chop.edu
13
Education:
21 9 B.S. 1f (Faculty of Science) c
63 Universidad Nacional Mayor de San Marcos, Lima Peru , 1959.
21 9 M.D. 20 (Faculty of Medicine) c
6d Universidad Nacional Mayor de San Marcos, San Fernando School of Medicine Lima, Peru, 1964.
c
3
3
3
3
8b
Permanent link21 9 B.S. 1f (Faculty of Science) c
63 Universidad Nacional Mayor de San Marcos, Lima Peru , 1959.
21 9 M.D. 20 (Faculty of Medicine) c
6d Universidad Nacional Mayor de San Marcos, San Fernando School of Medicine Lima, Peru, 1964.
c
2 29
21
1e
1d
24
5e
65
1e Kidney transplantation
19 Nephrotic syndrome
1a 29
27
Description of Research Expertise
4b Immunosuppressive therapy in Organ transplantation (kidney)65
Description of Clinical Expertise
27 Chronic kidney disease1e Kidney transplantation
19 Nephrotic syndrome
1a 29
23
fc Baluarte HJ, Palmer A, Petro J: Complications After Renal Transplantation. The Requisite Series: Pediatric Nephrology and Urology. Kaplan B, Meyers K (eds.). Elsevier Mosby 2005.
109 Baluarte HJ, Palmer J, Petro J: Management of the Pediatric Renal Transplant Recipient. The Requisite Series: Pediatric Nephrology and Urology. Kaplan B, Meyers K (eds.). Elsevier Mosby, 2005.
165 Pradhan M, Palmer J, Petro J, Meyers K, Baluarte HJ: Short term efficacy and safety of Atorvastatin in pediatric renal transplant recipients. Poster presentation at the 2nd. Congress of the International Pediatric Transplant Association, Rio de Janeiro, Brazil 7(4): 99, April 2003.
14b Prahan M, Petro J, Palmer J, Meyers K, Baluarte HJ: Early use of plasmapheresis for recurrent post-transplant FSGS. Poster presentation at the 2nd. Congress of the International Pediatric Transplant Association, Rio de Janeiro, Brazil 7(4): 64, April 2003.
cb Desai N, Mendoza JM, Petro J, Palmer J, Meyers K, Baluarte HJ, Brayman KL: Safety and Efficacy using Thymoglobulin in Pediatric Renal Transplantation. 4b Oral presentation at the American Transplant Congress, Washington DC 2a 5(3): 453, June 2003.
c2 Pradhan M, Palmer J, Petro J, Meyers K, Baluarte HJ: Short term efficacy and safety of Atorvastatin in Pediatric Renal Transplant recipients. 28 Oral presentation at the American 24 Transplant Congress, Washington DC 2b 5(3): 153, June 2003.
b1 Butani L, Polinsky MS, Kaiser BA, Baluarte HJ: Dietary protein intake significantly affects the Serum creatinine concentration 34 Kidney Int 61: 1907, 2002.
ae Lederman HM, Hurh PJ, Baluarte HJ: Polycystic Kidney Disease. EMedicine Journal 2(10), October 2001.
10e Silverstein DM, Palmer J, Polinsky MS, Braas, Baluarte HJ, Conley SB: Risk factors for hyperlipidemia in long-term Pediatric renal transplant recipients. Pediatric Nephrology 14: 105-110, 2000.
2c
7
1d
1f
Selected Publications
103 Baluarte HJ, Palmer J, Petro J: Evaluation for Pediatric Renal Transplantation. The Requisite Series: Pediatric Nephrology and Urology. Kaplan B, Meyers K (eds.). Elsevier Mosby, 2005.fc Baluarte HJ, Palmer A, Petro J: Complications After Renal Transplantation. The Requisite Series: Pediatric Nephrology and Urology. Kaplan B, Meyers K (eds.). Elsevier Mosby 2005.
109 Baluarte HJ, Palmer J, Petro J: Management of the Pediatric Renal Transplant Recipient. The Requisite Series: Pediatric Nephrology and Urology. Kaplan B, Meyers K (eds.). Elsevier Mosby, 2005.
165 Pradhan M, Palmer J, Petro J, Meyers K, Baluarte HJ: Short term efficacy and safety of Atorvastatin in pediatric renal transplant recipients. Poster presentation at the 2nd. Congress of the International Pediatric Transplant Association, Rio de Janeiro, Brazil 7(4): 99, April 2003.
14b Prahan M, Petro J, Palmer J, Meyers K, Baluarte HJ: Early use of plasmapheresis for recurrent post-transplant FSGS. Poster presentation at the 2nd. Congress of the International Pediatric Transplant Association, Rio de Janeiro, Brazil 7(4): 64, April 2003.
cb Desai N, Mendoza JM, Petro J, Palmer J, Meyers K, Baluarte HJ, Brayman KL: Safety and Efficacy using Thymoglobulin in Pediatric Renal Transplantation. 4b Oral presentation at the American Transplant Congress, Washington DC 2a 5(3): 453, June 2003.
c2 Pradhan M, Palmer J, Petro J, Meyers K, Baluarte HJ: Short term efficacy and safety of Atorvastatin in Pediatric Renal Transplant recipients. 28 Oral presentation at the American 24 Transplant Congress, Washington DC 2b 5(3): 153, June 2003.
b1 Butani L, Polinsky MS, Kaiser BA, Baluarte HJ: Dietary protein intake significantly affects the Serum creatinine concentration 34 Kidney Int 61: 1907, 2002.
ae Lederman HM, Hurh PJ, Baluarte HJ: Polycystic Kidney Disease. EMedicine Journal 2(10), October 2001.
10e Silverstein DM, Palmer J, Polinsky MS, Braas, Baluarte HJ, Conley SB: Risk factors for hyperlipidemia in long-term Pediatric renal transplant recipients. Pediatric Nephrology 14: 105-110, 2000.
2c